1. Home
  2. LEE vs KRRO Comparison

LEE vs KRRO Comparison

Compare LEE & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lee Enterprises Incorporated

LEE

Lee Enterprises Incorporated

N/A

Current Price

$6.37

Market Cap

169.6M

ML Signal

N/A

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$8.90

Market Cap

142.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEE
KRRO
Founded
1890
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
169.6M
142.0M
IPO Year
2025
2019

Fundamental Metrics

Financial Performance
Metric
LEE
KRRO
Price
$6.37
$8.90
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
★ $20.20
AVG Volume (30 Days)
32.7K
★ 162.2K
Earning Date
11-25-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $543,955,000.00
$6,392,000.00
Revenue This Year
$4.44
N/A
Revenue Next Year
N/A
$56.67
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 181.46
52 Week Low
$3.34
$5.20
52 Week High
$11.88
$46.28

Technical Indicators

Market Signals
Indicator
LEE
KRRO
Relative Strength Index (RSI) 30.98 34.73
Support Level $5.01 $8.29
Resistance Level $8.79 $14.32
Average True Range (ATR) 0.37 0.75
MACD -0.06 -0.05
Stochastic Oscillator 1.64 9.43

Price Performance

Historical Comparison
LEE
KRRO

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: